Director, Tulane University Heart and Vascular Institute
Tulane University
New Orleans, Louisiana, United States
Dr. Nassir F. Marrouche is a globally recognized electrophysiologist and pioneer in atrial fibrillation treatment. He is Professor of Medicine at Tulane University, Vice Chair of Innovation and Entrepreneurship in the Deming Department of Medicine, and Director of both the Tulane Heart and Vascular Institute and TRIAD research lab. He leads cross-disciplinary teams advancing prediction, prevention, and treatment of cardiovascular disease, with a focus on digital health solutions. Trained at leading institutions including Heidelberg, Cleveland Clinic, Harvard, UCSF, and the University of Washington, he is a Fellow of the ACC and HRS. Dr. Marrouche has authored over 200 peer-reviewed publications in journals such as NEJM, Circulation, and JAMA.
Disclosure(s): Abbott: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); AtriCure: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Biosense Webster: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Cardiac Designs: Family member CEO (Terminated), Stock-privately held company (Terminated); GE: Grant/Research Support (Ongoing); Marrek: Owner/Co-Owner Founder/Co-Founder (Ongoing); Medtronic: Grant/Research Support (Ongoing); Samsung: Grant/Research Support (Ongoing); Sanofi: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Siemens: Grant/Research Support (Ongoing)
Measuring Atrial Fibrillation Burden in the Era of Digital Health: SMURDEN
Monday, March 9, 2026
10:24 AM - 10:32 AM EST
Panel Discussion | Hope or Hype: Is the Cardiology Practice changing with AI?
Monday, March 9, 2026
10:40 AM - 11:00 AM EST
LEADLESS PACEMAKERS & EXTRA VASCULAR ICDS | A PARADIGM SHIFT FROM CONCEPT TO CLINICAL IMPACT
Monday, March 9, 2026
8:00 AM - 10:00 AM EST
Panel Discussion | The Role of Leadless Pacing and Extravascular ICD in 2025 and Beyond
Monday, March 9, 2026
8:48 AM - 9:10 AM EST
Live Case Broadcasting From MedStar Washington Hospital Center
Monday, March 9, 2026
9:10 AM - 10:00 AM EST
Monday, March 9, 2026
10:00 AM - 11:00 AM EST
Panel Discussion | Advancing the Science of Leadless Pacemakers
Monday, March 9, 2026
10:40 AM - 11:00 AM EST
INNOVATIONS IN ABLATION: PULSED FIELD ABLATION AND BEYOND
Monday, March 9, 2026
11:00 AM - 12:05 PM EST
Early Clinical Experience and Outcomes With PFA for Atrial Fibrillation
Monday, March 9, 2026
11:00 AM - 11:08 AM EST
Panel Discussion | The Future of Ablation with PFA
Monday, March 9, 2026
11:48 AM - 12:05 PM EST